Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

CG 201

Related Products

Hot Products

Basic Information Post buying leads Suppliers
Name

CG 201

EINECS N/A
CAS No. 5205-82-3 Density g/cm3
PSA 121.34000 LogP 3.22720
Solubility N/A Melting Point 134-135°C
Formula C22H28NO3•CH3O4S Boiling Point °Cat760mmHg
Molecular Weight 465.61 Flash Point °C
Transport Information N/A Appearance N/A
Safety Poison by subcutaneous and intravenous routes. Moderately toxic by ingestion and intramuscular routes. When heated to decomposition it emits toxic fumes of NOx and SOx. See also ESTERS. Risk Codes N/A
Molecular Structure Molecular Structure of 5205-82-3 (bevonium metilsulfate) Hazard Symbols N/A
Synonyms

bevonium metilsulfate;Piribenzil methyl sulfate;Bevonium

 

CG 201 Chemical Properties

IUPAC Name: (1,1-Dimethylpiperidin-1-ium-2-yl)methyl 2-hydroxy-2,2-diphenylacetate; methyl sulfate
EINECS: 226-001-8 
Melting point: 134–135 °C
Molecular Weight: 465.5597 g/mol

Molecular Formula : C23H31NO7S
Following is the structure:

Classification Code of CG 201 (CAS NO.5205-82-3 ) : Drug / Therapeutic Agent 

CG 201 Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 oral 1gm/kg (1000mg/kg) SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: EXCITEMENT
Arzneimittel-Forschung. Drug Research. Vol. 16, Pg. 901, 1966.
guinea pig LD50 oral 3860mg/kg (3860mg/kg) SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: EXCITEMENT
Arzneimittel-Forschung. Drug Research. Vol. 16, Pg. 901, 1966.
guinea pig LD50 subcutaneous 182mg/kg (182mg/kg) SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE

BEHAVIORAL: EXCITEMENT

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 16, Pg. 901, 1966.
mouse LD50 intraperitoneal 112mg/kg (112mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 11, Pg. 1423, 1969.
mouse LD50 intravenous 17400ug/kg (17.4mg/kg) SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: EXCITEMENT
Arzneimittel-Forschung. Drug Research. Vol. 16, Pg. 901, 1966.
mouse LD50 oral 1360mg/kg (1360mg/kg) SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: EXCITEMENT
Arzneimittel-Forschung. Drug Research. Vol. 16, Pg. 901, 1966.
mouse LD50 subcutaneous 436mg/kg (436mg/kg) SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: EXCITEMENT
Arzneimittel-Forschung. Drug Research. Vol. 16, Pg. 901, 1966.
rabbit LD50 intramuscular 500mg/kg (500mg/kg) SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 16, Pg. 901, 1966.
rabbit LD50 oral 1gm/kg (1000mg/kg) SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 16, Pg. 901, 1966.
rat LD50 intraperitoneal 222mg/kg (222mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 11, Pg. 1423, 1969.
rat LD50 intravenous 26mg/kg (26mg/kg) SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE

BEHAVIORAL: EXCITEMENT

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Arzneimittel-Forschung. Drug Research. Vol. 16, Pg. 901, 1966.
rat LD50 oral 5080mg/kg (5080mg/kg) SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Arzneimittel-Forschung. Drug Research. Vol. 16, Pg. 901, 1966.
rat LD50 subcutaneous 2400mg/kg (2400mg/kg)   Toxicology and Applied Pharmacology. Vol. 18, Pg. 185, 1971.
 

CG 201 Safety Profile

Poison by subcutaneous and intravenous routes. Moderately toxic by ingestion and intramuscular routes. When heated to decomposition it emits toxic fumes of NOx and SOx.

CG 201 Specification

  CG201 is such an improved formulation, which has been brought through preclinical evaluation studies in preparation for clinical trials in cancer patients.CG201 represents a great improvement in immunopotency over older anti-hCG vaccine formulations, yielding much higher levels of anti-hCG antibodies than possible with previous formulations. Its Synonyms are 2-(Hydroxymethyl)-1,1-dimethylpiperidinium methyl sulfate benzilate ; Acabel ; Benzilic acid ester with 2-(hydroxymethyl)-1,1-dimethylpiperidinium methyl sulfate ; Benzilsaeure-(N,N-dimethyl-2-hydroxymethyl-piperidinium)-ester-methylsulfat ; Bevonii metilsulfas ; Bevonium methyl sulfate ; Bevonium methylsulphate ; Bevonium metilsulfate ; Ester d'acide benzilique et du 1-methylsulfate de 1,1-dimethyl-(2-hydroxymethyl)piperidinium ; Ester del acido bencilico del 1,1-dimetil-2-oximetil-piperidinio-metilsulfato ; Metilsulfate de bevonium ; Metilsulfato de bevonio ; Piperidinium, 2-(hydroxymethyl)-1,1-dimethyl-, methyl sulfate, benzilate ; Piribenzil methyl sulfate ; alpha-Phenylmandelic acid N,N-dimethylpiperidinium-2-methyl ester methylsulfate .

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5205-82-3